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Abstract 
 
Background: Shigellosis and salmonellosis are still global health problems, especially, in 
developing countries where poor sanitation, lack of clean water supply and proper sewage 
disposal system exist. The emergence of increased antimicrobial resistance of Shigella and 
Salmonella species are global challenges, particularly in developing countries like Ethiopia 
where increased misuse of antimicrobial agents by human beings occur. 
Objectives: To determine the prevalence and antimicrobial susceptibility patterns of Shigella 
and Salmonella isolates from patients with diarrhea attending the health institutions in Gondar 
town, Northwest Ethiopia. 
Materials and Methods: Health institutional based cross sectional study was carried out on 
diarrheic patients attending Gondar town health institutions, February 29, 2014   to May 20, 
2014.  Systematic random sampling technique was used and stool samples were collected from 
372 study subjects.  Samples were  cultured onto MacConkey and Salmonella-Shigella agars and 
drug susceptibility patterns of the isolates were determined following standard bacteriological 
method. Data were coded and entered for statistical analysis using SPSS version 20. Data were 
presented using tables and chi-square and logistic regression was used for explanatory variables. 
Result: Of the total of 372 stool cultures, 17(4.57%) Shigella spp. and 4(1.08%) Salmonella spp. 
were isolated. Most commonly isolated strains of Shigella were S. flexneri 11(64.7%) followed 
by S. dysenteriae 3(17.65%), S. boydii 2(11.77%) and S. sonnei 1(5.88%). Shigella isolates 
presented high resistance rate to ampicillin (94.1%), amoxicillin (88.2), tetracycline (88.2%) and 
Salmonella species were highly resistance to tetracycline (100%), amoxicillin (100%), and 
ampicillin (75%). However, all isolates of Shigella and Salmonella were 100%susceptible to 
ciprofloxacin and norfloxacin.  
Conclusion and recommendation: This study revealed that isolates of Shigella and Salmonella 
showed high rate of drug resistance to the commonly used antibiotics. However, all the isolates 
were susceptible to ciprofloxacin, and norfloxacin. Therefore, ciprofloxacin and norfloxacin can 
be used as drugs of choice for the treatment of Shigellosis and Salmonellosis. 
Key words: Antibiotic susceptibility, prevalence, Salmonella and Shigella  
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1. Back ground and statement of the problem 
The Shigellae are members of the enterobacteriaceae,  non lactose fermenters, non motile, and 
non gas producers gram negative rods (1). There are four species of Shigella, which includes S. 
dysenteriae  (group A), S. flexneri ( gropuB), S. boydii ( group C), and S. sonnei ( group D) (1).  
Shigellae are transferred from person to person usually by asymptomatic carriers and via 
contaminated food, flies, faeces, fingers, and water (1). To initiate infection, as few as 100 
ingested Shigella organisms are enough. After the organisms enter the human body, they remain 
in the cytoplasm of the epithelial cells and spread laterally to invade adjacent cells which result 
in the formation of abscesses and ulcerations with high concentration of neutrophils in the stools 
(1). 
Shigellosis is only a human disease caused by the four species of genus Shigella and is 
characterized by increasing in frequency of stool motion and increase in number with the 
presence of blood, mucous and pus in the stool (1, 2). 
 
Shigellosis is endemic throughout the world where, it is held responsible for some 165 million 
cases of severe dysentery. The majority of these cases occur in the developing countries. More 
than one million people are estimated to die from Shigella infection each year. Since the late 
1960s, pandemic waves of Shigella dysentery had  striken Sub-Saharan Africa, Central America 
and East Asia (3). 
In Africa, an estimate of 115 people die of diarrheal diseases every hour, mostly of shigellosis 
and salmonellosis which  are  linked to  contaminated food and water due to poor sanitation and 
hygiene (4). In Ethiopia, one in every 17 Ethiopian children dies before the first birthday and one 
in every 11 children dies before the fifth birthday. According to the Ethiopian demographic and 
health survey (EDHS) report of 2011, 13 percent of the children under age five were reported to 
have had diarrhea, and 3% had diarrhea with blood in to the two-week periods before the survey 
(4). It is highest (18%) among children residing in households that drink water from unprotected 
wells. The prevalence of diarrhea in children residing in Amhara region was also found to be 
13.5% (4).    
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 Genus Salmonella are a member of enterobactericeae, non lactose fermenters, motile and gas 
producer gram negative rods (1). Transmission of these organisms are from person to person via 
fecally contaminated food, water or through direct faecal oral route (5, 6). They invade the 
mucosa of the small and large intestines and produce inflammation. Invasion of epithelial cells 
induces an inflammatory reaction which cause diarrhea due to salmonella (7). Salmonellosis is a 
disease caused by a large group of bacteria of the genus Salmonella (1).  
Two hundred million to more than one billion cases of diarrhea result worldwide due Salmonella  
infections every year, leading to 3 million deaths (5).The highest incidence of infection is among 
the very young and elderly. Mortality is highest in children less than one year old. The increase 
susceptibility of this age group may be due to the fact that children less than 2 months old 
produce little hydrochloric acid, a natural barrier to many microorganisms (5). 
The wide spread occurrence and distribution of Salmonella infection in Ethiopia is increased. It 
is due to contamination of water, food, and poor sewage disposal system. The very young, 
elderly, and immunocompromized individuals are particularly more susceptible to Salmonella 
infections at a lower infective dose than healthy adults (8). 
Due to different factors in the last few decades, Shigella  and Salmonella have become 
increasingly resistant to the most commonly used antimicrobials from time to time which results 
in some challenges in selecting the drug for therapeutic management (9, 10). The emergence of 
antibiotic resistant Shigella and Salmonella are serious problems in antimicrobial therapy 
globally. The incidence varies with the area of isolation of these strains. The progressive increase 
in antibiotics resistance among these pathogens in  developing countries is also becoming a 
critical area of concern (7). 
In developing countries like Ethiopia, resistance may be acquired mostly by selective pressure 
due to indiscriminate and misuse of antibiotics (11, 12). This leads for the emergence of  
resistance strains of Shigella and Salmonella which may be difficult for treatment and prevention 
(13, 14). In the 1940s, shigellosis was treated successfully with sulfa- drugs. In the 1950s, it was 
treated with tetracycline (5). In the 1970s ampicilin was the drug of choice for the treatment of 
bacillary dysentery (15). After the pathogen  began to develop resistance to  ampicilin  the new 
drug trimethoprime- sulphamethoxazole(TMP-SXT) was used (16). Even if the drug of  choice 
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in that time was TMP-SXT, in the 1980s, the Shigella species started to develop  resistance to the 
drug (17). Then the emergence of resistance strains continues with any new drugs. 
Until about 1960, nearly all Salmonellae were sensitive to a wide range of antimicrobial agents 
but since 1962 emergence of resistance, frequently plasmid mediated, have appeared in 
Salmonella worldwide. The relative importance of antibiotic resistance, and the serotypes  in 
which it occurs, differs from country to country (5). 
Knowing the prevalence and the local patterns of antimicrobial susceptibility of Shigella and 
Salmonella  species is important for reducing the burden of the diseases(7). Therefore, the aim of 
this study is to determine the prevalence and susceptibility patterns of Shigella and Salmonella 
isolates from patients with diarrhea attending the health institutions in Gondar town, Northwest 
Ethiopia. 
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2. Literature review 
2.1 Shigellosis  
In most cases, shigellosis in developed countries was due to S.sonnei, where as shigellosis in 
developing countries was due to S.flexneri followed by S.dysenteriae (7, 18, 19).     
A report in the United States indicates that an average of 20,000 to 30,000 cases per year were 
reported. S.sonnei accounted nearly 80% of all Shigella isolates while S.dysenteriae accounted 
nearly 1%  (1). This finding was in line with studies done in Tehran and Trinidad which showed 
that the major species causing shigellosis was S. sonnei (20, 21). However, in Abidjan, Côte 
D’Ivoire the predominant species were S. flexneri followed by S. boydii, S.sonnei, S. dysenteriae 
(22). 
A study conducted in Iran, on children who had diarrhea, indicated that the prevalence of 
shigellosis was high (14.5% ) whereas, a community based study done in southern Trinidad 
showed the prevalence of shigellosis was relatively low (8%) (20, 22).    
The  frequency of isolation, distribution  and  prevalence of Shigella species varies from time to 
time and from region to region (23). In Iran, the most frequently isolated species was S.sonnei 
followed by S. flexneri, S.boydii, and S. dysenteriae (21) which was in line with  a report in 
Trinidad (20) and in Ethiopia, S.flexneri was the most frequent followed by S.dysemnteriae, 
S.boydii, and S. sonnei (13, 24). In a study done in Indonesia, the prevalence of shigellosis on 
children having diarrhea, showed 9.3%  (25) whereas study conducted  in Côte D’Ivoire showed 
that the prevalence rate of Shigella among diarrheal patients was 2.9% (22) and in Ethiopia, 
Gondar (7.5%)  (24).  
A hospital based study conducted in Tanzania on patients with bloody diarrhea, the Shigella 
species isolated were 69(14%). Of the 69 Shigella species isolated, 62(90%) were S.flexneri, 
7(10%) were S.dysenteriae, and none of them were found to be  S.boydii and S. sonnei  (19) 
whereas a surveillance study done  in Kenya indicated that 16%(549/3445) were positive (26). 
Moreover, another study done in Kenya showed that the prevalence of Shigella was 43.7% (27).   
Cross sectional study conducted in Southwest Ethiopia, Jimma on pediatric out patients having 
diarrhea 77/384 (20.1%) were positive, in which S.flexneri was the most common followed by 
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S.dysenteriae and S.boydii. Of these isolates, more than 53% were resistance to tetracycline, 
ampicilin, cephalotin and 25-40% were resistance to trimethoprim-sulphamethoxazole, 
carbencillin(28) whereas a health institutional based study conducted in Ethiopia, Hawassa on 
diarrheal patients showed,100/ 289 (34.6%) were positive for shigellosis and 99(99%) were 
S.flexneri and 1(1%) were S.dysenteriae and all the isolates were susceptible to nalidixic acid and 
gentamycin (29). 
A study conducted in Ethiopia, Hawasa, on stools of children showed the rate of isolation for 
Shigella was 7 % (30) and another cross sectional study done in Ethiopia, Hawassa, on stools of 
food handlers in catering establishments at Hawassa University showed the prevalence of 
shigellosis was 0.4%  (31) whereas in Jimma on the same study group the prevalence of Shigella 
was 2.3% (32) and in Harar it was 6.7% (33). 
Of the 76 isolates of Shigella from Ethiopia Addis Ababa, S.flexneri was the most frequent(54%) 
followed by S.dysenteriae (22.4%), S.sonnei (15.8%), and S.boydii (7.8%) (13), while another 
study done in  Ethiopia, Gondar, showed that the prevalence of  Shigella were (7.5%) (24) and  
(3.1%) (34). Among the 90 isolates of Shigella the most common species were  S.flexneri 
(72.2%) followed by S.dysenteriae (10%), S.boydii (8.9%), and S.sonnei (8.9%) (34).  
Another cross sectional study conducted in Ethiopia, Gondar  Hospital showed that the 
prevalence of Shigella was 15.6% (12) and a retrospective study done on the same area also 
reported as 7.4% (35). Moreover, a cross sectional study on the same area in HIV infected and 
uninfected patients from 2003 -2004 indicated  that  of the 391 stool samples (8.7%) were 
positive (36) which was different from a study on this area on diarrheal patients(16.9%) on 384 
stool specimens positive for shigellosis (34). 
2.2 Salmonellosis 
Salmonella species are leading causes of acute gastroenteritis in different countries, especially in 
the developing countries like Ethiopia where substandard hygienic conditions and unsafe  water 
supplies are common (37). 
The World Health Organizations estimated 16 million new cases of salmonellosis and an 
estimated of  600,000 deaths of typhoid fever were reported (38). 
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A hospital  based study in china on diarrheal patients showed that the prevalence was 3.58%, of 
8405 diarrheal cases, 301 were positive  and S.thyphemerium and S.enrerica were commonly  
isolated (39). 
The prevalence rates of salmonellosis were varies from the age groups. A study which was done 
in Brazil on under five children showed that the pathogen were found more: other persons  who 
were carriers and who were taking care of them may have transmitted to them by hands and 
foods (40). However, a study  done in Nigeria indicates that the prevalence of salmonellosis 
increased as age increased (41). 
A hospital based study done in Tanzania on the stools of bloody diarrhea showed that the 
prevalence of Salmonella was 0.8%(19) whereas a study done in Kenya  showed  the prevalence 
of Salmonella was 3.3% (27).   
A cross sectional study conducted in Ethiopia, Jimma reported the prevalence of Salmonella as 
15.4% (42) and another study done in the same area jimma  showed that the prevalence of 
Salmonella was 6.2% (32)  whereas study conducted in Ethiopia, Hawasa on children with 
diarrhea showed that the prevalence of Salmonella was 2.5%(30). 
In a study conducted in Ethiopia ,Harar, the prevalence of Salmonella was 11.5%(33) whereas in 
another cross sectional study done in Ethiopia ,Hawasa,  on  food handlers of catering Hawassa 
University showed no Salmonella species was  isolated (31). However, another study which was 
conducted in Gondar, Ethiopia showed 1.6% (12). 
    2.3. Antimicrobials susceptibility patterns of Shigella and Salmonella  
Shigella and Salmonella species were resistance to the commonly used drugs such as  
tetracycline, amoxicillin, ampicilin, cotrimoxazole, trimethoprime-sulphamethoxazole whereas 
they were frequently  sensitive to  naldixic acid, norfloxacin, ciprofloxacin, gentamycin (7, 13, 
24, 29). However, study done in Hawasa  showed that  Salmonella spp. was highly sensitive to 
the  commonly used antibiotics: ampicilin (100%), tetracycline (100%), chloramphenicol (100), 
cotrimozaxxole (100%), amoxacilin (100%), and gentamycin (100%)  (30). 
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 A cross sectional study which was done in Eastern Ethiopia, Harar on diarrheal patients showed 
that the  sensitivity of the Salmonella isolates were 0.0% to ampicillin; 0.0% to amoxicillin; 
14.2% to tetracycline; 28.6% to chloramphenicol; 89.3% to norfloxacin; and 92.8% to 
gentamicin and  Shigella had sensitivities of 0.0% to ampicillin; 0.0% to amoxicillin; 11.8% to 
tetracycline; 41.2% to chloramphenicol; 88.2% to norfloxacin; and 94.1% to gentamicin (33) 
which was in line with study done in Ethiopia, Gondar showed that the continued sensitivity of 
Shigella to gentamycin, and ciprofloxacin and their wide spread resistance to tetracycline, 
ampicilin, cotrimoxazole, and chloramphinicol (35). 
Study conducted in Ethiopia, Gondar on Serodiversity and antimicrobial resistance patterns of 
Shigella isolates showed that all the isolates had highest resistance rates to tetracycline (90%), 
cotrimoxazole (84.5%), ampicilin (78.9%), chloramphinicol (67.8), and low resistance rate to 
gentamycin (12.2), ciprofloxacin (2.2%), and norfloxacin (1.1%). All the isolates was sensitive 
to naldixic acid and ceftriaxone(24). Moreover, study on the same area showed the highest 
resistance to Tetracycline (87.7%), Ampicillin (81.5%), Co-trimoxazole (75.4%), 
Chloramphenicol (50.8%), and low resistance  rate to Gentamycin (10.7%) , and Ciprofloxacin 
(9.2%) (7). 
 
 
 
 
 
 
 
 
 
8 
 
3. Significance of the study 
 
Diarrheal diseases are the main health problems in developing countries. In Ethiopia, diarrheal 
diseases which include shigellosis and salmonellosis are said to be common and are difficult to 
manage because of the emergence of drug resistance strains of the agents. About half of the 
Shigella and Salmonella isolates obtained from Ethiopian patients with diarrhea had shown multi 
drug resistance patterns to the commonly used antibiotics. These finding indicates that our 
communities suffer from drug resistance shigellosis and salmonellosis. Therefore, the present 
study may address the distribution of Shigella and Salmonella and their patterns of antimicrobial 
susceptibility which may have a paramount importance for researchers, policy makers, local , 
regional, and  national  health administrative and awareness of professionals to look for a 
possible means of control and preventive majors. 
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4. Objective of the study      
General objective 
 To assess the prevalence and antimicrobial susceptibility patterns of Shigella and Salmonella 
species among patients with diarrhea attending Gondar town health institutions, Northwest 
Ethiopia. 
    Specific Objectives 
 To determine the prevalence of Shigella among patients with diarrhea attending health 
intuitions in Gondar town. 
  To determine the prevalence of Salmonella species among patients with diarrhea 
attending health intuitions in Gondar town. 
 To determine antibiotic susceptibility patterns of Shigella and Salmonella isolates. 
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5. Materials and Methods  
        5.1 Study area 
The study was conducted in Gondar town health institutions. Gondar is a capital city of North 
Gondar administration zone, in Amhara region, Northwest Ethiopia. The town is located at 748 
km r from Addis Ababa, the capital city of Ethiopia and 180 km from Bahir dar. The zone has an 
estimated total population of 3,245,577, with a male to female ratio is 1:1 and has 34 woredas 
and 3 Hospitals. Specifically the town has an estimate of > 300,000 total populations (43) with 
one referral hospital (University  of Gondar Referral  Hospital) and 8 health centers that include 
Woleka, Gondar, Gebrieal, Ginbot 20, Maraki, Azezo, Tseda, and Blajig Health Centers which 
are currently giving health service to the community.  
5.2. Study design and period 
Health institutional based cross- sectional study was conducted from January 2014 to May 2014. 
5.3 Populations 
         5.3.1. Source population  
All the populations who were living in and around Gondar town were the source of population. 
         5.3.2. Study population  
 The study populations were patients having diarrhea attending health institutions in Gondar 
town during the study period. 
5.4. Inclusion criteria 
 All patients with diarrhea.  
5.5. Exclusion criteria 
 All patients with diarrhea who had taken antibiotics treatment in the last 14 days  and /or 
all patients who were not lived in Gondar for the last one week. 
    5.6 Variables 
      5.6.1.   Dependent variable  
- Prevalence of Shigella and Salmonella species 
- Antimicrobial susceptibility patterns of Shigella and Salmonella species 
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   5.6.2. Independent variables 
The independent variables of the study are: 
age, sex, residence, occupation, hygienic standard, availability of toilet, type of water source 
used, accessibility of health institutions  
  5.7. Sample size determination and Sampling technique. 
Taking prevalence from the previous study which was conducted in Gondar town, Ethiopia 
(16.9%) on diarrheal patients (7), Using 95 % of confidence interval with 4% of margin of 
error sample size was calculated as follows.  
N=
          
  
 
Where: 
n = No of sample that will be included  
  
 
 = confidence level  
P= prevalence from the previous study.  
W= acceptable difference  
 n= 
                       
      
 
           n= 338 
Adding the 10 % contingency 372 
So, the sample size was 372 
Systematic random sampling technique were used. 
In the study area all the patients who were attended in one month before study was 539. 
The estimated number of patients in the data collection time (February 29 -May 20) was 
1437. 
To determine the k value. Population size (N) =1437, sample size=372 
         k=N/n=1437/372=3.86, K=4 
Then every 4
th
  cases of diarrheal patients were selected as study subjects. 
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5.8. Data collection and Laboratory methods 
Socio-demographic characteristics was assessed and recorded from the study participants by 
pretested structured questionnaire. 
Sample collection and processing  
Stool samples from diarrheic patients were  collected in a clean, dry, disinfectant-free suitable 
wide-necked container and immediately transferred to Selenite F broth as a transport medium 
and inoculate onto Salmonella-Shigella agar (Oxoid) and MacConkey (Oxoid), and incubated at 
37
0
C for 24 hours. After incubation, the plates  were examined for growth and gram stain was 
done and further bacterial species were identified following standard biochemical test procedure. 
Biochemical tests performed were triple sugar iron agar, indole, urea, Simon’s citrate agar, lysine 
iron agar, and motility tests. Shigella species were  serogrouped by the slide agglutinations test 
using commercially available polyvalent O antisera for S. dysenteriae, S. flexneri, S. boydii and 
S. Sonnei (38). 
Antimirobial Susceptibility test   
SSuspension of test organisms were  prepared by picking pure colonies with a sterile wire loop 
suspended in sterile nutrient broth and incubated for 2 hrs (38). The density of suspensions to be 
inoculated were  determined by comparing with 0.5 McFarland standards. A sterile cotton swab 
was used and the excess suspension was removed by gentle rotation of the swab against the 
surface of the tube and then spread evenly over the Muller Hinton agar plate. Susceptibility 
testing was performed on isolates using agar disc diffusion technique against   ampicillin (10 
µg), amoxicillin (10µg), tetracycline (30 µg), trimethoprime-sulphamethoxazole (30µg), 
gentamycin ( 10µg), kanamycin (25µg), nalidixic acid (30 µg),  chloramphenicol (30µg),  
norfloxacin(10µg), ciprofloxacin (5µg)) and cefaclor (30 µg ). he plates will be left   at room 
temperature for 30 minutes   for diffusion then incubated for 18-24 hours at 37
0
C. After 18-24 
hrs, the zone of growth of   inhibition around each disc was measured in millimeters, using a 
metal caliper, and interpreted as sensitive; intermediate and resistance following the method of 
CLSI(38, 44). 
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Data Quality control 
The reliability of the study findings was guaranteed by implementing quality control (QC) 
measures through the whole process of the laboratory work. All materials, equipment, and 
procedures were adequately controlled. Culture media was tested for sterility and performance. 
Pre analytical, analytical, and post analytical stage of quality assurance those  were  incorporated 
in standard operating procedures (SOPs) of the Microbiology Laboratory at the University of 
Gondar was strictly followed.  Standard reference strains of E.coli ATCC 25922 and 
Pseudomonas aeruginosa ATCC 27853 were used to chech the performance of culture medias,  
biochemical tests and antimicrobial discs (38, 44). 
5.9. Data Analysis and Interpretation  
Data were  checked for completeness and all responses to the questionnaire were coded against 
the original English version and analysis was made by using SPSS version 20 software.Data 
were analyzed by  using tables and chi-square. Logistic regression was used for explanatory 
variables. P-values  ≤ 0.05 were considered as statistically significant. 
5.10. Ethical Considerations 
Ethical clearance was obtained from research and ethics committee of the School of Biomedical 
and Laboratory Sciences, College of Medicine and Health Sciences, University of Gondar. 
Permissions were obtained from the concerned bodies of the Zonal Health office and selected 
health institutions. Informed consent was obtained from each study participants.  For each 
confirmed cases, the responsible clinician of the patient was informed and treatment was started 
as per the guideline. For children assent was obtained from their parents or guardians.  
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6. Results  
6.1 Socio - demographic characteristics  
A total of 372 study participants were included in this study, of which 180 (48.4 %) were males 
and 192 (51.6 %) were females. The ages of the study participants ranged from 1 to 84 years 
with a mean age of 21.18. Among the study participants 274 (73.7%) lived in urban areas. One 
hundred two (27.4%) diarrheic patients were from primary school and majority 147 (39.5%) of 
the diarrheal patients were under 18 years who are not eligible for legal labor working (Table 1) 
Table 1: Socio-demographic characteristics of diarrheic patients attending Gondar town health 
institutions, Northwest Ethiopia, February to May 2014 
 
**Under 18 years-they are illegible for work, *under 5 years-they are illegible for school. 
Characteristics  Number   Per cent    
      
Sex  
     Male 
     Female 
Age in ( years) 
     <20 
     20-40 
     41-60 
      ≥61 
Educational status 
     Under 5 years *                                                      
     Illiterate  
     Wright and read  
     Primary school (1-8) 
     Secondary school (9-12)  
     College/University 
  
180 
192 
 
189 
139 
32 
12 
 
68 
35 
58 
102 
74 
35 
  
48.4 
51.6 
 
50.8 
37.4 
8.6 
3.2 
 
18.3 
9.4 
15.6 
27.4 
19.9 
9.4 
 
Occupational status  
     Government employees 
      Private employees 
      Non employees 
      Merchant 
      Farmer 
      Under 18 years ** 
  
33 
39 
99 
29 
25 
147 
  
8.9 
10.5 
26.6 
29.8 
6.7 
39.5 
 
Residence  
      Urban 
      Rural  
  
274 
98 
  
73.7 
26.3 
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6.2 Prevalence of Shigella and Salmonella species  
Of the 372 study participants with diarrheal diseases 17(4.57%)  Shigella spp. and 4(1.08%) 
were Salmonella spp were isolated. Of the Shigella spp  isolates, 11 (64.7%) were S. flexneri, the 
predominant isolates followed by S. dysenteriae 3(17.65%), S. boydii 2(11.77%) and S. sonnei 
1(5.88%) (Table 2).   
Table 2. The frequency of Shigella  and Salmonella species isolated from diarrheic patients 
attending Gondar town health institutions, Northwest Ethiopia, February to May 2014  
 
6.2.1 Clinical characteristics of diarrheal patients  
 Fever, abdominal pain, vomiting, headache were the major clinical symptoms of the patients in 
this study (Table 3). Of the total participants, abdominal pain was found to be 315(84.7%) of the 
study subjects 
 Table 3. Clinical characteristics of diarrheic patients attending Gondar town health institutions, 
Northwest Ethiopia, February to May 2014  
Clinical characteristics   Number    per cent  
Abdominal pain 
         Yes 
         No  
  
315 
57 
 
84.7 
15.3   
Vomiting 
        Yes 
        No  
  
164 
208 
   
44.1 
55.9 
Bacterial isolates     Number (%) 
Shigella speies  17 ( ) 
S.flexneri     11(64.7) 
S.dysenteriae     3(17.65) 
S.boydii 
S.sonnei 
    2(11.77) 
    1(5.88) 
Salmonella species  4( ) 
Total  21 (100) 
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Fever 
      Yes 
       No  
  
233 
139 
   
62.6 
37.4 
Headache  
     Yes  
      No 
 
214 
158 
 
57.5 
42.5 
Joint pain 
      Yes 
       No  
 
161 
211 
 
43.3 
56.7 
 
Of the 17(4.57%) Shigella isolates, bloody diarrhea was found in 6(35.32%) and mucoid diarrhea 
was 7(41.1%) whereas watery diarrhea was 3(17.6%) and 8(47.1%) had previous diarrhea 
(  ==0.51,     , p value=0.599) 
 
 
6.2.2 Risk factors for shigellosis and salmonellosis  
Majority of the Shigella spp. isolated from patients who ate their food in street vendors, other 
compounds and hotels were 10(58.8%), x (%),  respectively,   while 7(41.2%) were who had 
eaten  in their home.  Most of them did not have liquid waste disposal system 11(64.7%) and 
they had used non-boiled water 16(94.1%). Thirteen (76.5%) patients did not wash hands before 
preparing food (  =2.15,     , p value=0.143) whereas only 5(29.4%) washed their hands 
after defecation. Age of the patients was not associated with shigellosis (ᵡ2=0.661,     , p-
value= 0.882) and sex of the patients had also not associated with shigellosis (  =0.777,     , 
p-value=0.378). Bivariate and multivariate logistic regressions were employed but none of the 
variables were statistically significant with shigellosis. 
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6.3 . Antimicrobial  susceptibility pattern of Shigella and Salmonella species  
The antimicrobial susceptibility patterns of the Shigella and Salmonella isolates were presented 
in Table 4. Strains of Shigella species were resistant to ampicilin (94.1%), tetracycline (88.2%), 
amoxicillin (88.2%), but susceptible to norfloxacin (100%), and ciprofloxacin (100%). 
Salmonella isolate were also resistant to ampicilin (75%), amoxicillin (100%) and 
tetracycline(75%), but highly susceptible to norfloxacin(100%) and ciprofloxacin(100%). 
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Table 4.Antimicrobial susceptibility patterns of Shigella and Salmonella isolates diarrheic patients attending Gondar town health 
institutions, Northwest Ethiopia, 2014. 
 
 
 
 
 
 
 
Key: AMP-Ampicillin, Amox-Amoxacillin, TTC-Tetracycline, CN-Gentamycin, K-kanamycin, NA-Nalidixic acid, CEF-Cefaclor, 
SXT-Trimethoprime-Sulphamethoxazole, C-Chloramphenicol, NOR-Norfoloxacin, CIP-Ciprofloxacin. 
 
 
 
 
 
Bacterial 
isolates 
Resistance Pattern to antimicrobial agents 
Number (%) 
AMP AMOX TTC CN   K NA CEF   SXT    C NOR CIP 
Shigella(n=17) 16(94.1) 15(88.2) 15(88.2) 7(41.2) 7(41.2) 5(29.4) 11(64.7) 10(58.8)    3(17.6)  0(0) 0(0) 
Salmonella(n=4) 3(75) 4(100) 3(75) 1(25) 1(25) 1(25) 4(100) 2(50) 0(0) 0(0) 0(0) 
total  21 19(84.55) 19(94.1)  18(81.6)  8(33.1)  8(33.1)  6(27.2)  17(82.35) 12(54.4)  3(17.6)  0(0)  0(0) 
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6.3.1 Multiple  Antimicrobial resistance pattern of Shigella and Salmonella isolates  
The results of multiple antimicrobial resistant patterns were presented in Table 5. Of the 
17(4.57%) of the Shigella isolates 16(94.1%) showed multi-drug resistant, while one of them 
was sensitive to all antimicrobial agents tested. The Shigella spp. showed multi drug resistance 
up to 8 antibiotics and the Salmonella spp. showed up to 5 antibiotics   
 Table 5: Multidrug-resistance pattern of Shigella and Salmonella isolates from diarrheic patients 
attending Gondar town health institutions, Northwest Ethiopia, February to May 2014 
Key: AMP-Ampicillin, Amox-Amoxacillin, TTC-Tetracycline, CN-Gentamycin, K-kanamycin, 
SXT-Trimethoprime-Sulphamethoxazole,C-Chloramphenicol, NA-Nalidixic acid, CEF-Cefaclor 
NOR-Norfoloxacin, CIP-Ciprofloxacin. 
 
 
Bacterial 
isolates  
 
Number of 
antibiotics 
resisted 
Antibiotics tested Total (%) 
 
 
 
 
Shigella species  
 
 
R4 
AMP, AMOX, TTC, SXT 2(12.5%) 
AMP, AMOX, TTC, CEF 2(12.5%) 
AMP, TTC, CF, NA 1(6.25% 
 
R5 
AMP, AMOX, TTC, CN,KAN  1(6.25% 
AMP, AMOX, SXT, CF, NA 1(6.25% 
AMP, AMOX, CF, CN, NA 1(6.25% 
 
R6 
 
AMP, AMOX, TTC, SXT, CEF, KAN  1(6.25% 
AMP, AMOX, TTC, SXT, CEF, NAL 1(6.25% 
AMP, AMOX, TTC, SXT, CN, KAN  1(6.25% 
AMP, AMOX, TTC, SXT, CEF, CN 1(6.25% 
AMP, AMOX, TTC, CEF, KAN, NAL 1(6.25% 
R7 AMP, AMOX, TTC, SXT, CEF, CN, KAN 2 (12.5%)   
R8 Amp,  Amox, TTC, SXT, CEF, CN, K, C 1(6.25%) 
Salmonella 
species  
 
 
R3 AMOX, CEF, AMP 1(25%) 
R4 AMOX, CEF, AMP, SXT  2(50%) 
R5  AMOX, CEf, AMP, CN, K 1(25%) 
21 
 
7. Discussion   
In this study, the isolation rate (4.57%) of Shigella spp. was almost in line with studies from 
Indonesia (9.3%) (25) and Trinidad (8%) (20). This was  lower than studies done in Tehran 
(14.5%) (21), Kenya:(16%) (26), (43.9%) (27). The low rate of isolation as observed in the 
present study may be due to differences in the method of sample collection, isolation 
identification. The rate of Shigella (Table 2) was also lower than previous studies in Ethiopia: 
Jimma (20.1%) (28), Hawasa (34.6%) (29) , and Gondar: (16.9%) (7), (15.6%) (12) but in 
agreement with Harar (6.7%) (33) and Gondar :7.4%(35), 7.5%(24). However, higher than study 
from  Hawasa (0.4%) (31). This might be due to differences in awareness of the people about 
personal and environmental hygiene from the continuous health education made by the different 
health educators in the different health institutions against of shigellosis and salmonellosis. 
In the current finding  the isolation rate (1.076%) of  Salmonella spp. was found to be lower than 
studies done in Ethiopia  at different places: Harar (11.5%) (33), Jimma : (15.4% ) (42), (6.2%) 
(32).  However, it was consistent with  the findings reported in Tanzania (0.8%) (19) and in 
Ethiopia: Hawasa: (0%) (31),  (2.5%) (30), Gondar: (1.6%) (12), and (0%) (34). This might be 
due to the increasing awareness of the people about personal and environmental hygiene made 
by the health institutions and other partners.  
Our findings showed that S. flexneri (64.7%) (Table 2) was the predominant serogroup in the 
present study which was found to be  higher than the finding reported in Addis Ababa (54.0%) 
(13), and lower than the findings reported in Tanzania (90%) (19), Gondar (72.2%) (24)  and  in 
line with  a report in Indonesia (63.2%) (25). However, the prevalence of S .flexneri at the same 
study area decreased from (72.2 %) in 2008 (24) to (64.7%) in the present study, whereas the 
prevalence of S. dysentriae increased from (10%) in 2008 (24) to (17.65%) in the present study. 
The current finding indicated that S. Sonnei (5.88 %) (Table 2) were the least frequently isolated 
spp. which was in line with the previous study conducted in the same study area 8.9%((24). 
Majority of Shigella isolates were found in mucoid diarrhea 8(47.1%), not washing hands after 
defecation 12 (70.6%) and not washing hands before preparing food 13 (76.5%). However, it 
was not stastically significant associated  with an increasing of infection with Shigella wich was 
in line with study done on childhood diarrhea in sub-saharan africa  (45). 
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The emergence of antibiotic resistance among Shigella and Salmonella spp. isolates are serious 
problems in antimicrobial therapy globally, especially in developing countries. The incidence 
varies with the area of isolation of these strains (7). When results of the antimicrobial 
susceptibility patterns of Shigella and Salmonella species in this study compared with earlier 
reports from other parts of Ethiopia showed that there has been a change in resistance pattern to 
antibiotics use in Ethiopia. It showed a high degree of resistance to the commonly used 
antimicrobials. Similar observations were also reported in Indonesia(25), Iran(23), Tehran(21), 
and Ethiopia(13, 32, 33) (Table 8). According to this study, therefore: ampicillin, tetracycline, 
amoxicillin and SXT are no longer effective for the treatment of shigellosis and salmonellosis in 
the study area 
More than 58% of Shigella isolates were resistance to amoxacillin, tetracycline, ampicillin, 
cefaclor, and 29-42% of the isolates were resistance to gentamicin, kanamycin, and nalidixic 
acid. This was much higher than the findings reported in the 1980s, and 1990s(45).The resistance 
to all other antibiotics in this revealed higher rate of resistance than the findings reported in the 
1980s, 1990s and (45). This may be due to overuse of antimicrobials in the area. 
In this study, the overall multiple drug resistance pattern of Shigella were 16(94.1%) of the 
isolates (Table 5); this was higher than studies conducted in Ethiopia, Gondar: (87.8%) (35) and 
(68%) (34) and lower  than study done in Jimma (100%) (32). 
The present study showed that there was an increasing frequency of resistance of Shigella  
strains to nalidixic acid (58.8%) and gentamicin (41.2%)  as compared with the previous reports 
in Ethiopia: nalidixic acid (2.7%) (13) and gentamicin (0%) (13) and nalidixic acid(0%) (24) and  
gentamicin (12.2%) (24). 
We identified no resistance to chloramphenicol, norfloxacin and ciprofloxacin. Other studies also 
found that little resistance to chloramphenicol,  norfloxacin and /or no resistance to ciprofloxacin 
at the same study area (24, 34).Thus, at the present time ciprofloxacin and norfloxacin are the 
best drugs of choice for the treatment of  shigellosis and salmonellosis in the study area. 
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8. Limitation of the study   
 Due to unavailability of antisera, serotyping of Salmonella isolates was not possible. 
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9. Conclusion  
This study confirmed that Shigella and Salmonella spp. are the causative agents of diarrheal 
diseases.  S .flexneri was the predominate spp. isolated followed by S. dysenteriae, S .boydii, S. 
sonnei. All Salmonella spp. were resistant against amoxicillin and Cefaclor whereas one strain of 
Shigella as susceptible to all antibiotics. Most of the Shigella and Salmonella isolates were 
resistance against ampicillin, amoxicillin, tetracycline, cotrimoxazole but all are susceptible to 
norfloxacin and ciprofloxacin. The Shigella and Salmonella species showed high level of 
multidrug resistance to the commonly used antibiotics. 
10. Recommendation  
 It is recommended to establish an antimicrobial resistance surveillance system for 
Shigella and Salmonella species in different regions of Ethiopia. 
 Physicians and clinicians should use ciprofloxacin and norfloxacin as first line antibiotics 
for the treatment of shigellosis and salmonellosis.  
 Avoid overuse of antibiotics to reduce the emergence of multi-drug resistance strains. 
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12. Annexes 
 
Annex I. Information Sheet and Consent Form 
Title of the research project  
Prevalence and antimicrobial susceptibility pattern of Shigella and Salmonella species among 
diarrheal patients who are attending health institutions in Gondar town, Gondar, North West 
Ethiopia 
Name of the principal investigator: Tesfaye Andualem 
Name of the organization: University of Gondar, Gondar college of Medicine and Health 
Sciences. 
Information sheet and consent form prepared for patients who have diarrhea to the study 
participate in this research project. 
Purpose of the research project  
The aim of this study is to assess the prevalence and antimicrobial susceptibility pattern of 
Shigella and Salmonella species among diarrheal patients who are attending health institutions in 
Gondar town, North West Ethiopia. The results of this study will be used to design appropriate 
intervention programs to reduce the incidence of the diseases in Gondar town. 
Procedure 
The study involves diarrheal patients in Gondar town health institutions. You are selected to be 
one of the study participants if you are willing to take part in this study and we kindly invite you 
to take part in our project. If you are willing to participate, we are so happy and we need you to 
clearly understand the aim of this study and show your agreement. Finally you are kindly 
requested to give your genuine response in the interview. 
Benefits risk and /or Discomfort 
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By participating in this research project you may feel some discomfort in wasting your time (a 
maximum of 15 minutes). However, yours participation is definitely necessary for determining 
the prevalence and antimicrobial susceptibility pattern of Shigella and Salmonella species among 
diarrheal patients and to design appropriate strategies and planes to decrease the disease burden . 
There is no risk or direct benefit in participating in this research project. 
Confidentiality  
The information collected from you will be kept confidential and stored in a file, without your 
name by assigning a code number to it, and no report of the study ever identifies you. 
Right to refusal or withdraw 
You have the full right to refuse from participating in this research. You have also the full right 
to withdraw from this study at any time you wish. 
Person to contact 
This research project will be reviewed and approved by the ethical committee of the University 
of Gondar. If you have any question you can contact the following individual and you may ask at 
any time you when want. 
Tesfaye Andualem    Tele: +251 912877914 
E-mail:   tesfayeandu@gmail.com 
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Annex II 
የ መረጃ  ቅፅ በአማረኛ 
የ ትናቱ ረዕስ፡ --የ ተቅማጥ በሽታን ሉያስከትለ የ ሚችለትን ተዋስያንን መሇየ ትና የ ፀ ረ- ተህዋሥያን 
መዴሀኒት  የ መቋቋም  ባህሪያቸዉን   ማጥናት፡ ፡  
የ ተመራማሪው ስም፡   ተስፋዮ አንደአሇም 
የ ዴርጅቱ ሰም፡  በጎ ንዯር ዮንቨረስቲ ህክምና ጤና ሳይንስ ኮላጅ የ ህክምና ሊብራቶሪ ትምህርት ክፍሌ 
የ ትናቱ አሊማ፡   አስፍሊጊ የ ሆኑ የ መከሊከያ ዘዳዎችን በመንዯፍ  ህመም እና ሞትን መቀነ ስ ነ ው:: 
የ ትናቱ አተገ ባበር ፡  ፍቃዯገ ኛ ስሇሆኑ እኛ በጣም ዯስተኞች ነ ን ፡ ፡  በመጨረሻም የ ፍቃዯዎን በእርስዎ 
አስፈሊጊ ነ ው የ ሚለትን መሌስ እንዱሰጡን እንጠይቃሇን፡ ፡  
ጥቅም አዯጋናአሇመመቸት፡ - በዚህ ምርምር በመሳተፍው በቀጥታ የ ሚያገ ኚት ጥቅም ሊይኖር ይችሊሌ፡ ፡ ነ ገ ረ 
ግን ወዯ 15 ዯቂቃ ከስራው ጊዜዎን ሉያባክኑ ይችሊለ፡ ፡  
ሚስትራውነ ት፡ - በዚህ ምርምር ፕሮጀክት የ ተሰበሰበ መረጃ ሚስትራዊ ይሆናሌ፡ ፡ በዚህ ቅፅ የ ረሰዎ ስም 
አይፃ ፍበትም በተጨማሪም እርስዎ ከሚሰጡን መረጃ ጋር አይያያዝም 
ያሇመሳተፍ ወይም  የ ማቋርጥ መብት፡  በዚሀ ጥናት ያሇመሳተፍ ፍፁም የ ሆነ  መብት አሇውት፡ ፡  
ሇተጨማር ዝርዝር መረጃ፡ -  ከዚህ በታች ባሇው አዴራሻ ዋና ተመራማሪውን ወይም የ ትናቱን  አማካሪዎች 
ማግኘት ይቻሊለ፡ ፡  
 
ተስፍዩ አንደአሇም     ሞባይሌ 2510912877914 
 
 ተስፋዩ አንደአሇም( ተመራማሪ)               ሞባይሌ    0912877914 
 ፕሮፌሰር ሞገ ስ ጥሩነ ህ( አማካሪ)           ሞባይሌ   0918810357 
 ድክተር ፈሇቀ ሞገ ስ  (አማካሪ)             ሞባይሌ    0918776160 
 አቶ ዲኛቸው ሙለየ   (አማካሪ)          ሞባይሌ    0918031335 
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Annex III: questionnaire  
University of Gondar 
College of Medicine and Health Sciences 
School of Biomedical and Laboratory Sciences 
Department of Medical Microbiology 
Determining the prevalence and antimicrobial susceptibility patterns of Shigella and Salmonella 
spp. among diarrheal patients who are attending health institutions in Gondar town, North West 
Ethiopia 
Written consent  
Greeting  
Hello!! My name is _____________________________________. I am working as data 
collector in the survey conducted by University of Gondar, College of Medicine and Health 
Sciences, Department of Medical Microbiology. These questionnaires are prepared to assess the 
prevalence of Shigella and Salmonella and theirs antimicrobial susceptibility pattern isolated 
from stool specimens of diarrheal patients. You are kindly requested to be included in the study, 
which will have importance in reducing the risk of shigellosis and salmonellosis .The interview 
will take about 15 minutes and no information concerning you, as an individual will be passed to 
another individual or institution without your agreement. Your participation is voluntary and you 
have the right to not participate fully or partially. If you agree to be included in the study I will 
start my questions by asking general identifications points.  
This study is designed to generate information for program expansion and to know the drug of 
choice for the treatment of the patients who are with shigellosis and salmonellosis and elsewhere 
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with similar characteristics. To attain this purpose, your honest and genuine participation by 
responding to the question prepared is very important. 
For children assent will be obtained from their parents or guardians.  
Confidentiality and consent  
We would like to know your some personal issues, your answers and ideas are completely 
confidential in secured. Your name will not be written on this form. You can refuse to answer a 
sing question even to the extent to stop the interview at any time you want if you are not 
comfortable. We appreciate your kindness to be part of the study. The interview will take about 
15 minutes. Are you willing to participate? 
If the answer yes                                          continue interviewing  
                       No        stop interviewing  
Section 0: Questioner Identification 
01-date------/------/------ 
02-Questioner identification ------------------------ 
Notice: first write or circle the appropriate answer on the coding categories & also  
Put on the coding column. 
I. Socio demographic characteristics  
1. Sex    A. Male □    B. Female □ 
2. Age (years) ___________________ 
3. Occupation.   A. government employed□ B. self employed □ C.non employed □ D. 
Merchant □ E. Farmer □ 
4. Education.  A.  Illiterate □ B. Only read and Wright□ C. Primary school (1-8) □ D. 
Senior secondary school (9-12) □ E. College diploma and above□. 
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5. Residence  A Urban □ B. Rural□ 
                     II. Clinical profile  
1. Did u have abdominal pain? 1.Yes  □  2.No□ 
2. Did you have headache?  1.Yes □        2.No □ 
3. Did you have vomiting?   1.Yes □         2.No □ 
4. Did you have fever??        1.Yes  □        2.No □ 
5. Did you have joint pain?    1.Yes  □     2.No□ 
6.  Did you have previous diarrhea?  A. Yes  □     B.No □ 
7.  If yes for how long it was? A.1-7 day  □   B.8-13 days  □  C.14 days and above □ 
8.  If yes for questions no 6 what types of diarrhea it was? A. Watery □      B.Mucoid □  
C. Bloody □ 
9. What was its status?  A.  Stopped □  B. Worse □  C. Treatment □ 
10.  For how long the present diarrhea? A.1-7 day □ B.8-13 days □  C.14 days and 
above□ 
11.  What types of diarrhea it is? A. Watery□      B. Mucoid□   C. Bloody□ 
12. Where you were ate food from the following places in the last 7- days? A. Home□   
B. Restaurant  □   C. street vendor □  C. another compound □ 
13. Water source   A. River □     B. Unprotected spring □   C. Unprotected well □   D. 
Protected spring□  E. Stagnant water  □   F. Protect well  □    G.  Pipe □ 
36 
 
14. How did you use the water? A. Boiling□     B. Water guard□   C. Not boiling  □  
15.  Is the health institution accessible?  A. Yes □     B. No□ 
16. What type of toilet do you have in your house? A. Simple  Pit latrine □  B. open field 
□ 
17. Do you wash your hands after defecating? A. Yes □     B. No□ 
18. If yes!  A. Regularly with soup □   B. Irregularly with soap□     C. Without soap □   
D. Not at all □ 
19. Do you wash your hands before preparing food? A. Yes□      B. No□ 
20. If yes!  A. Regularly with soup □   B. Irregularly with soap□     C. Without soap □   
D. Not at all□ 
21. Is there solid or liquid waste disposal within the living compound? A.Yes  □  B.No □ 
22. If yes   A. Did you use it   □ B. Not used  □ 
23. If yes for questions no 26, it is nears to yours home?  A. Yes □   B. No □ 
24. If yes for questions no 26, is it cleaned regularly?   A. Yes □   B. No □ 
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Annex IV; structured Amharic questions  
  በጎ ንዯር ዩንቨረስቲ ህክምናእና ጤና ሳይንስ ኮላጅ የ ህክምና ሊብራቶሪ  ትምህርት ክፍሌ 
የ ተቅማጥ በሽታ ጥናት አሰሳ 
የ ሚ ስጥር አጠባበቅ ስምምነ ት 
 
ጤና ይስጥሌኝ  አኔ -------------------------- ባሇሁ በጎ ንዯር ዩንቨርሲቲ ህክምና 
ፋካሉቲ የ ህክምና ሊብራቶሪ ተቋም የ ጥናት ቡዴን አባሌ ነ ኝ፡ ፡  
 
የ ዚህ ጥናት ኣሊማ በአካባቢው ፡  ---  በተቅማጥ ወሇዴ በሽታዋች የ ተያዙ ሰዎችን የ በሽታ መጠን ና 
በሽታውን ሉያጋሌጡ   የ ሚችለ  ተዋስያንን በተመሇከተ ጥናት ማካሄዴ ነ ው፡ ፡  
ሇመሳተፍ ፍቃዯኛ ነ ውት? 
1. አዋ--------------መሌሱ አዋ ከሆነ  ወዯሚቀጥሇው ጥያቄ ዕሇፍ/ፊ/ 
2. የ ሇም------------መሌሱ ከሆነ  አመስግነ ህ/ሽ / ጥያቀቄውን አቓርጭ /ጥ/ 
መጠይቁን የ ሞሊው ሥም -------መጠይቁ የ ተዯረገ በት ቀን---------/------/2006ዓ.ም--
------ 
በዚህ ጥናት ሇመሳትፍ ፍካዯኛ ከ ሆኑ ጥያቄውችን በማንሳት እጀምራሇሁ፡ ፡  
                                                           የ ጥናቱ 
ተሳታፊ መሇያ ቀጥር-------------------------- 
                1. የ ማህበራዊ ጥያቄዎችን በተመሇከተ 
1. ጾታ.      A ወንዴ □    B.ሴት □ 
2. እዴሜ(ዓመት)     ----------------------- 
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3. ስራ.    A.)  የ መንግስት ተቀጣሪ □   B.)  የ ግሌ ተቀጣሪ   □     C.)  ስራ 
የ ላሇው   □      D.) ነ ጋዳ   □     E.) አረሶአዯር □       
4.  የ ትምህርት ዯረጃ. A.) ማንበብእና መጻፍ የ ማይችሌ □    B.) ማንበብእና መጻፍ የ ሚችሌ 
□    C. ) 1ኛ ዯረጃ(1-8) □     D.)2ኛ ዯረጃ(9-12) □          E.) 
ዱፕልማ እና ከዚያ በሊይ □  
5. የ መኖሪያ ቦታ   A.)ገ ጠር  □    B.)ከተማ □ 
 
2.ከተቅማጥ ህመም ጋር የ ተያያዙ ጥያቄዎች 
1. ሆዴ ህመም ይስማዎታሌ?    A.) አዎ  □      B.) የ ሇም □  
2. ያስታዉከዎታሌ /ያስመሌሰዎታሌ?             A.) አዎ  □      B.) የ ሇም □  
3. ትኩሳት አሇዎት?        A.አዎ)  □      B.) የ ሇም □  
4.  የ ራስ ህመም ይሰማዎታሌ? A.) አዎ  □      B.) የ ሇም □  
5. የ መገ ጣጠሚያ ህመም ይሰማዎታሌ?.A.)አዎ  □      B.) የ ሇም □  
6. ከዚህ በፊት የ ተቅማጥ በሽታ ይዞዎት ያውቃሌ?  A.) አዎ □     B.) የ ሇም  □  
7.  አዎ ከሆነ  ሇምን ያህሌጊዚያት ነ በር?     A.) 1-7 ቀናት □   B.) 8-13ቀናት□   
C.) 14 ቀናት እና ከዚያ በሊይ□ 
8. ሇ6ኛ ጥ ያቄ አዎ ከሆነ   ምንአይነ ት ተቅማት ነ በረ?  A.) ውሃ የ መሰሇ□    B.) ንፍጥ 
መሳይ የ ተቀሊቀሇበት □   C.) ዯም የ ተቀሊቀሇበት□ 
9.  ሇ6ኛ ጥ ያቄ አዎ ከሆነ    የ ተቅማቱ ሁኔታ ዕ ነ ዳት ነ በር?  A.) ወዱያውኑ የ ቀመ □   
B. )   በጣም አስክፊ□   C.) በህክምና የ ቆመ □  
10. አሁን በሽታው ከያዝዎት ሇምን ያህሌ ጊዜ ሆነ ዎት?   A.) 1-7 ቀናት□    B.) 8-13  
ቀናት □   C.)14 ቀናትእና ከዚያ በሊይ□ 
11. የ አሁኑ ምንአይነ ት ተቅማት ነ ው ? A.) ውሀየ መሰሇ □   B.) ንፍጥ መሳይ የ ተቀሊቀሇበት 
□       C.) ዯም የ ተቀሊቀሇበት□ 
12.  ከሚከተለት ውስጥ ሊሇፉት 7 ቀናት የ ት ነ በር የ ተመገ ቡት  A.) ከቤት የ ተዘጋጀ□    
B.)ከሆቴሌ □    C.) ከመንገ ዴ ዲር  የ ተዘጋጀ□           D.)ከጎ ረቢት ቤት 
□ 
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13. ሇአገ ሌግልት የ ሚጠቀሙብት ውሃ ከየ ት ነ ው የ ሚያገ ኙት? A.)  ከወንዝ □    B.) 
ካሌተጠበቀ ምንጭ □   C. )ካሌተጠበቀ ኩሬ □  D.)ከተጠበቀ ምንጭ□    E.) 
ከተጠበቀ ምንጭ□  F.)ከቆመ ውሃ□    G.)ከቧንቧ □   ከጉዴጓዴ□ 
14. .ሇመጠጥ የ ሚጠቀሙበት ውሃ እንዳት ነ ው የ ሚጠቀሙት A.)ውሃ አጋር ጨምርው □  B.)አፍሌተው 
□ C.)ሳያፈለ □  
15.  የ ጤና ተቋም በአካባቢዎ አሇ? A.) አዎ □    B. )የ ሇም  □  
16.  የ ሚጠቀሙት ሽንትቤት አይነ ት የ ትኛው ነ ው?  A.) ከሜዲ ነ ው የ ሚፀዲደት □    B.) 
የ ተሇምድ ሽንት ቤት □  C.) ሽታ አሌባ ሽንት ቤት□ 
17. እጅዎን ከመፀዲጃ ቤት እነ ዯወጡ ይታጠባለ         A .) አዎ□   B.) የ ሇም □  
18. አዎ ከሆነ     A.)ሁሌጊዜ በሳሙና ይታጠባለ□     B.)አሌፎ አሌፎ በሳሙና ይታጠባለ □    
C.)ያሇሳሙና ይታጠባለ□ 
19. እጅዎን ምግብ ከማዘጋጀተዎ በፊት ይታጠባለ?   A.) አዎ□    B.) የ ሇም □ 
20. አዎ ከሆነ     A.)ሁሌጊዜ በሳሙና ይታጠባለ□   B.)አሌፎ አሌፎ በሳሙና ይታጠባለ □    
C.)ያሇሳሙና ይታጠባለ□ 
21. የ ፍሳሽ እና የ ዯረቅ ቆሻሻ መጠያ በአካባቢዎ አሇ?     A.) አዎ□   B.) የ ሇም □ 
22. አዎ ከሆነ            A.)ይጠቀሙበታሌ □       B.)አይጠቀሙበትም □ 
23. ሇ26 ጥያቄ አዎ ካለ ሇመጠቀም ቅርብ ነ ው   A.) አዎ□    B.) የ ሇም □  
24.  ሇ26 ጥያቄ አዎ ካለ በየ ጊዜው ይፀዲሌ     A.) አዎ□    B.) የ ሇም □  
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Annex V Materials used in the study  
-MacConkey agar  
-Salmonella Shigella agar 
-Muller Hinton agar  
-Triple sugar iron agar  
-Selenite F broth  
-Simon's citrate agar   
-Lysine decarboxylase agar  
-Urea agar base   
- Motility agar 
-Kovac's reagent 
-Sterile cotton wool  
- Antibiotic disks  
- Wire loop  
- Sprit lamp 
- Petri dish 
- Slide, matches 
-Diethyl ether 
-Antibiotics  
 
Reagent; crystal violate 
-Gram's iodine 
-Acetone alcohol, safranin 
-Cotton, test tube, gauze, forceps 
 -McFarland standard 
-Test tube rack 
-Disposable glove, ruler   
-Aluminum foil 
- Immersion oil 
-Microscope 
-A balance and weighing papers 
- A 1-liter Erlenmeyer flask, cotton plugged    
or screw capped  
- A 1-liter graduated cylinder 
-Water proof marker, pen, pencil, paper 
-Normal saline (0.85%
w
/v) 
 - A 1-liter glass beaker  
  -Distilled water 
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Annex VI. Sampling selection procedure  
The first step will include selection of sources, collection of samples, transportation to the 
laboratory, isolation and identification of Shigella and Salmonellae on the basis of their colony 
morphology, staining property, motility and biochemical and serological characteristics. In the 
second step, the current statuses of drugs sensitivity and resistance patterns of isolated bacteria 
will determine. 
After collection, each sample will inoculate in to freshly prepare Selenite F broth identified into 
tube properly and incubated at 370C for 24 hours aerobically in bacteriological incubator. Then, 
a loop full of bacterial culture from incubated tubes will streak separately into the Salmonella-
Shigella agar (SSA), McConkey agar (MCA). The plates will examine and study carefully for the 
presence of characteristic colonies of Shigella and Salmonella. The representative Shigella and 
Salmonella colonies will characterize morphologically using Gram’s staining methods and 
identifying with biochemical tests 
Susceptibility of the isolated Shigella and Salmonella to different antibacterial agents will 
perform through disc diffusion method to determine the drug sensitivity pattern. 
Stool 
                  
Streaked on  
 
  
SS agar                                                                                          MacCkonky agar 
                                                                                                                                                         
                           
                                                                                                              NLF colonies and L 
                                                                                                        
NLF colonies are specific 
For Salmonella and Shigella 
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                                        Bio chemical tests  
                                                                                             
   
     
                                                
 
 
                                                
 
                                 
 
 
                                                    Antimicrobial susceptibility testing  
                                       Figure 1 
The figure in the above shows that identification of Shigella and Salmonella species and their 
antimicrobial susceptibility pattern. 
                    Antimicrobial susceptibility testing 
Procedure 
1. Prepare a suspension of the test organism by emulsifying colony of the organism in a small 
volume of nutrient broth 
2. Much the turbidity of suspension with turbidity standard 
3. With a sterile swab take sample from the suspension (squeeze the swab against the side of 
the test tube to remove the excess fluid). 
Oxidase-negative 
Motility –negative 
Indole-positive 
Citrate- negative 
Urease-negative 
TSI-   Negative for H2S and gas  
Shigella  
Oxidase –negative 
Motility –positive 
Indole –negative 
Citrate-positive/negative 
Urease -negative 
TSI- positive  for H2S and gas 
Salmonella 
 
 
 
 
 
 
 
 
  
 
Motility-positive 
Indole –negative 
Citrate-positive/negative 
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4. Spread the inoculum evenly over the Muller-Hinton agar plate with the swab 
5. Using a sterile forceps or needle, place the antimicrobial disc on the inoculated plate 
6. Incubate the plate aerobically at 35-37oC for 18-24 hours 
7. Read the test after checking that the bacterial growth is neither heavy nor light. Measure the 
radius of the inhibition zone. 
8. Interpret the reaction of the test organism to each antibiotics used as sensitive, intermediate, 
or resistance as per the standard 
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